Background/Aims: MicroRNAs (miRNAs) are a novel class of small RNAs that participate in a variety of biological processes. Although miRNAs have been linked to insulin synthesis and glucose homeostasis, their role in the targeting of mitochondrial uncoupling protein 2 (UCP2), a negative modulator of insulin secretion, remains unclear. Methods: miRNA levels were determined by real-time quantitative PCR analysis using TaqMan probes, and insulin secretion from isolated islets was quantified by ELISA. Effects of miRNAs on UCP2 expression were checked with a luciferase assay and western blotting analysis. Results: An overall change in a set of miRNAs was discovered, with miR-15a, miR-424, miR-497, and miR-185 coinciding with insulin levels in islets maintained under high-glucose conditions. Moreover, experiments in MIN6 cells illustrated that miR-15a, miR-424, miR-497, and miR-185 positively regulated insulin biosynthesis by co-inhibiting UCP2 expression. Furthermore, the four miRNAs were found to post-transcriptionally repress UCP2 expression by directly targeting the 3'UTR of UCP2 mRNA. Conclusions: Thus, our results shed further light on the regulatory network in β-cells consisting of miRNAs, UCP2, and insulin and provide novel therapeutic targets for diabetes.
Introduction
Diabetes is a complex, multisystem disease and the most common metabolic disorder [1, 2] . Type 2 diabetes is characterized by insulin resistance, with or without abnormal insulin secretion, leading to insufficient insulin production and subsequent diabetes mellitus [3, 4] . Pancreatic β-cells as well as their endocrine product insulin play central roles in glucose homeostasis and diabetes pathogenesis, and glucose is the main stimulator of insulin biosynthesis and secretion [5, 6] . However, the direct molecular mechanism of glucosestimulated insulin secretion (GSIS) is still unclear.
MicroRNAs (miRNAs) are a family of small noncoding RNAs [7] that plays important roles in various biological pathways by post-transcriptionally inhibiting the expression of genes via base pairing to the target mRNAs [8, 9] . miRNAs also play fundamental roles in a wide variety of biological processes, including developmental timing, apoptosis, proliferation, differentiation, the immune response, and energy metabolism [8, 9] .
Mitochondrial uncoupling protein 2 (UCP2) belongs to the superfamily of mitochondrial anion carriers that is located in the inner membrane of mitochondria [10] . UCP2 is believed to uncouple oxygen consumption during respiration and reduce ATP production by mediating proton leaks [11] . UCP2 is a negative regulator of insulin secretion, with islets of UCP2 knockout mice generating much more insulin [12] and UCP2 overexpression in isolated rat islets inhibiting GSIS [13] .
Increasing evidence shows that miRNAs participate in the insulin secretion process [14, 15] . miR-133a and miR-375 enhance insulin secretion by repressing polypyrimidine tract-binding protein and myotrophin protein expression, respectively [16] [17] [18] . However, the interaction between miRNAs and insulin release remains unclear.
miR-15a, miR-424, miR-497, and miR-185 are implicated in human cancer, metabolic processes, the immune escape of tumor cells, and many other disease processes [19, 20] . However, few studies have focused on their role in β-cell function. In this study, miR-15a, miR-424, miR-497, and miR-185 were identified as positive regulators of GSIS. These miRNAs were first identified because they showed a clear variation in mouse islets exposed to high glucose. MIN6 cells overexpressing the four miRNAs showed a marked increase in insulin secretion, whereas knockdown of the four miRNAs inhibited insulin secretion. Subsequently, all of the miRNAs were found to directly target UCP2 mRNA and to regulate insulin secretion by inhibiting UCP2 expression. The miRNA levels in UCP2-deficient mouse islets were in accordance with those in wild-type mouse islets, showing that the four miRNAs were upstream regulators of insulin secretion, with UCP2 in the downstream position. Therefore, this study helps to explain this novel pathway, comprising glucose, miRNA, and insulin, in β-cell function.
Materials and Methods
Animals C57/BL6 mice (6-8 weeks) were purchased from the Model Animal Research Center of Nanjing University. All animal care and handling procedures were performed in accordance with the National Institute of Health's Guide for the Care and Use of Laboratory Animals and approved by the Institutional Review Board of Chengdu Military General Hospital, Chengdu, China.
Isolation of islets from mouse pancreas
Islet isolation was performed as previously described with slight modifications [21] . Mice were anesthetized by intraperitoneal injection of sodium pentobarbital. Pancreatic islets were then isolated by pancreatic duct injection of 500 U/ml of collagenase solution followed by digestion at 37°C for 28 min with mild shaking. Islets were washed several times with D-Hanks (136 mM NaCl, 0.53 mM KCl, 4.2 mM NaHCO 3 , 0.44 mM KH 2 PO 4 , 0.385mM Na 2 HPO 4 .12H 2 O), separated from acinar cells using a discontinuous Ficoll 400 gradient, viewed under a dissecting microscope, and hand-selected. Finally, the islets were collected and transferred into RPMI1640 medium containing 10% fetal bovine serum.
Islets were cultured at 37°C in a humidified atmosphere containing 5% CO 2 /95% air for 12 h (primary culture) to remove exocrine and other tissues. Subsequently, islets were transferred into Dulbecco's modified Eagle's medium (DMEM) containing 5.6 or 28 mM glucose for insulin secretion studies.
RNA isolation and PCR assays
Total RNA was extracted from the cultured cells and mouse islets using TRIzol Reagent (Invitrogen) according to the manufacturer's instructions. Assays to quantify mature miRNAs were conducted as described previously, and real-time PCR was performed using a TaqMan PCR kit. In this study, miRNA expression in cells and islets was normalized to U6 snRNA. The relative amount of each gene to the internal control was calculated by using the 2 -ΔCT equation, in which ΔCT = C T gene -C T U6 . To determine the mRNA expression of UCP2 and insulin, the following primers were designed: UCP2 (sense): 5'-TCAGAATGGTGCCCATCACA-3', UCP2 (antisense): 5'-CCGGTTACAGATCCAAGGAGAA-3'; insulin (sense): 5'-CACTTCCTACCCCTGCTGG-3', insulin (antisense): 5'-ACCACAAAGATGCTGTTTGACA-3'; GAPDH (sense): 5'-AGAAGGCTGGGGCTCATTTG-3', GAPDH (antisense): 5'-AGGGGCCATCCACAGTCTTC-3'. mRNA expression was evaluated using agarose polyacrylamide gel electrophoresis with GAPDH as the internal control.
Determination of insulin secretion
Secreted insulin was measured using the Rat/Mouse Insulin ELISA Kit (EMD Millipore; catalog number, EZRMI-13K). Insulin secretion was assessed as described; batches of 10 islets each were incubated in DMEM. For the measurement of insulin secretion from islets exposed to long-term (72 h) high glucose, the medium was removed at the 71st hour, fresh DMEM with the desired amount of glucose was added, and medium was collected on the 72nd hour for ELISA analysis.
To determine the insulin secretion of MIN6 cells, medium was removed from the wells and the cells were washed twice with PBS. Then, FBS-free DMEM with 5.6 mM glucose was added to each well and the cells were cultured for another 1 h. Mature insulin from MIN6 cells was normalized to total insulin.
Cell culture MIN6 cells were routinely maintained in RPMI 1640 supplemented with 20% heat-inactivated fetal bovine serum (FBS), 1% glutamine, 1% β-mercaptoethanol, and 10 mM HEPES. Cells were cultured at 37°C with 5% CO 2 .
MIN6 cells were routinely maintained in DMEM supplemented with 10% heat-inactivated fetal calf serum and cultured at 37°C with 5% CO 2 . MIN6 cells were treated with 5 mM glucose in RPMI for 18 h and then with 2.5 mM glucose in KRB buffer (135 mM NaCl, 3.6 mM KCl, 10 mM HEPES [pH 7.4], 5 mM NaHCO 3 , 0.5 mM NaH 3 PO 4 , 0.5 mM MgCl 2 , 1.5 mM CaCl 2 ) for 1 h. The cells were stimulated with KRB buffer containing 5.6 or 33 mM glucose for 1 h or 3 days. Lysates from these cells were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis. Insulin was measured by immunoblot analysis using guinea pig antimouse insulin antibody (ab7842, Abcam).
Cell transfections MIN6 cells were seeded on 6-well plates and transfected by using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. For each well, equal doses (100 nM) of miRNA mimics, inhibitors, or scrambled negative control RNA were used. For the co-transfection of miRNAs, the total concentration was 100 nM, with equal amounts of each miRNA. Cells were harvested 24 h after transfection for real-time PCR analysis and western blotting.
Plasmid construction and luciferase assay
Part of the 3'-untranslated region (UTR) segment (1-50) of UCP2 was synthesized and inserted into a p-MIR-report plasmid (Ambion). Then, a plasmid with a mutated 3'UTR of UCP2 was also built with the same method. For luciferase reporter assays, 2 μg of firefly luciferase reporter plasmid, 2 μg of β-galactosidase expression vector (Ambion), and equal amounts (200 pmol) of mimics, inhibitors, or scrambled negative control RNA were transfected into cells in 6-well plates. The β-galactosidase vector was used as a transfection control. At 24 h after transfection, cells were assayed using luciferase assay kits (Promega).
Western blot analysis UCP2 expression was assessed by western blot analysis and sample levels were normalized to GAPDH. Protein extraction was blocked with 5% fat-free dried milk in PBS at room temperature for 1 h and incubated at 4°C overnight with anti-UCP2 (1:1000, Santa Cruz) and anti-GAPDH (1:1000, Santa Cruz) antibodies.
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Statistical analysis
All data are representative of at least three independent experiments. Data are expressed as the mean ± standard deviation of three separate experiments. A p value less than 0.05 using the Student's t-test was considered significant. * indicates p<0.05, ** indicates p<0.01, and ***indicates p<0.001.
Results

Effects of high glucose on the expression of β-cell UCP2
Mitochondrial UCP2 is regarded as a negative modulator of insulin secretion [22] . Accumulating evidence indicates that the β-cell levels of UCP2 may be upregulated by glucolipotoxicity, which decreases insulin secretion [23] . In this study, the effects were assessed of both short-and long-term high glucose on UCP2 expression in islets. The UCP2 concentration was lower in islets treated with short-term high glucose than in islets cultured in normal glucose medium (5.6 mM), whereas UCP2 was significantly increased in islets cultured under long-term high-glucose conditions (Fig. 1A and 1B) . The observations confirmed that UCP2 is an important regulator during glucose-induced insulin secretion and that UCP2 negatively regulates insulin secretion. However, UCP2 mRNA showed little change under both conditions (Fig. 1C) . These findings suggest that glucose regulates UCP2 expression at the post-transcriptional level.
Short-and long-term effects of high glucose on UCP2-related miRNAs
Glucose is regarded as the main stimulator of insulin biosynthesis and its rapid secretion from β-cells [5] . Glucose-induced insulin expression in islets may be partly regulated by autocrine factors, including miRNAs. In the present study, four significant miRNAs were identified for their potential interaction with UCP2 mRNA via bioinformatics methods (Fig.  1D) .
The levels of miR-15a, miR-424, miR-497, and miR-185 were increased in islets treated with high glucose for 1 h (Fig. 1E) , whereas they showed a relative decrease after 72-h stimulation (Fig. 1F) .
These data suggested that upregulation of the four miRNAs may positively regulate insulin secretion from islets, whereas their downregulation may impair insulin secretion. 
miRNA expression levels in UCP2 knockout and ob/ob mouse islets are consistent with those in wild-type mouse islets
To determine whether the four miRNAs were upstream regulators in the GSIS pathway, we next checked the effects of high glucose on miRNA expression in UCP2 knockout mouse islets. As shown in Fig. 2A , short-term exposure to high glucose significantly increased the expression levels of miR-15a, miR-424, miR-497, and miR-185 in UCP2-deficient mouse islets. In contrast, the four miRNAs showed a relative decrease under the effects of long-term high glucose (Fig. 2B) . Insulin secretion was clearly higher from UCP2 knockout islets than from wild-type islets (Fig. 2C) . These results were in accordance with those from wild-type mouse islets.
Ob/ob mice are a well-known diabetes model. Here, we also checked the expression pattern of the four miRNAs and UCP2 in the islets of ob/ob mice. miR-15a, -424, -497, and -185 showed little change with short-and long-term glucose (Fig. 2E and 2F ). Islet UCP2 is upregulated in diabetes; our results showed that 1-h exposure to high-glucose could not suppress UCP2 expression in the islets of ob/ob mice (Fig. 2G) .
These results illustrated that high glucose affected miRNA expression in β-cells without the intermediary regulation of UCP2.
miR-15a, miR-424, miR-497, and miR-185 directly target the 3'UTR of UCP2
To determine the target genes of miR-424, miR-497, and miR-185 in β-cell function, we first obtained the candidates of the four miRNAs via bioinformatics methods and found that they might all regulate UCP2 expression (Fig. 3A) . In addition, part of the 3'UTR of UCP2 containing the predicted target regions was fused into a downstream position of the firefly luciferase plasmid. The plasmid was introduced into 293T HEK cells in conjunction with a transfection control plasmid (beta-gal). As expected, overexpression of the four miRNAs significantly decreased luciferase reporter activity compared with scramble ncRNA (Fig. 3B) . However, the reporter activity repression was almost fully rescued when the target regions were mutated (Fig. 3B) .
miR-15a, -424, -497, and -185 promote insulin section in MIN6 cells by suppressing UCP2
To study the physiological role of the four miRNAs in β-cells, MIN6 cells were transfected with mimics and inhibitors of miR-15a, miR-424, miR-497, and miR-185. Real- 
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time quantitative PCR analysis showed that the four miRNAs were respectively increased and decreased significantly by the appropriate mimics and inhibitors ( Fig. 4A and 4B ). Overexpressed miR-15a, -424, -497, and -185 down-regulated UCP2 levels ( Fig. 4C and 4E ), whereas transfection of miRNA inhibitors slightly promoted UCP2 expression ( Fig. 4D and  4F ). The overexpression of miR-15a, miR-424, miR-497, and miR-185 in MIN6 cells led to increased secretion of insulin (Fig. 4G) , whereas MIN6 cells with knockdown of the miRNAs showed a clear decrease in insulin secretion (Fig. 4H) . Thus, the four miRNAs positively regulate insulin secretion in MIN6 cells.
Silencing of UCP2 promotes insulin secretion
To further confirm that UCP2 plays a key role in β-cell function, we used siRNA to knockdown UCP2 in MIN6 cells. Both mRNA and protein were suppressed by the siRNAs (Fig. 5A-5C ). As expected, silencing of UCP2 significantly promoted insulin secretion from MIN6 cells (Fig. 5D ). In addition, co-transfection of UCP2 siRNA and miR-15a, -424, -497, and -185 did not lead to further changes compared with the UCP2 siRNA group. These findings clearly demonstrate that miR-15a, miR-424, miR-497, and miR-185 directly repress UCP2 translation in β-cells through a post-transcriptional mechanism.
Discussion
The number of identified miRNAs is continuously increasing, but the information regarding their roles in biological processes and cellular function remains limited. Thus far, several miRNAs have been reported to participate in diabetes development, as well as insulin biosynthesis and secretion [15, 24] . However, because few studies have focused on the miRNA-insulin network, it is still difficult to obtain a comprehensive understanding of the potential mechanism. One of the main challenges to understanding the function of miRNAs is to identify their genuine target genes in β-cells.
Glucose is an important regular of β-cell function, with short-and long-term highglucose conditions having different effects on insulin secretion [25, 26] . Islet β-cells are able to immediately improve insulin secretion in response to high-glucose stimulation, whereas prolonged high glucose, known as glucolipotoxicity, decreases insulin secretion [25] [26] [27] . Although a few studies have focused on this phenomenon, the differences between the mechanisms of short-and long-term high glucose remain unclear. One explanation for the insulin decrease induced by prolonged high glucose is that high glucose itself may contribute to β-cell dysfunction [27, 28] . On the other hand, we believe that miRNAs play a key role in this process, considering that several miRNAs showed clear variations in mouse islets exposed to high glucose.
Although UCP2 shares high identity with UCP1, and both of them have uncoupling activity, the primary physiological role of UCP2 remains unknown [10] . The mild uncoupling effects of UCP2 are likely to play a signaling role [11] , and miRNAs may participate in the UCP2-mediated biological process [29] . Studies based on UCP2 knockout mice have shown that UCP2 inhibits insulin secretion [12] and accumulating evidence indicates that β-cell UCP2 is upregulated by prolonged glucolipotoxic conditions [13, 22] . Our results are in concordance with those of the previous studies.
Because miR-15a has been reported to inhibit β-cell UCP2 expression [30] , it was used as a positive control. miR-424, miR-497, miR-185, and miR-15a showed clear variations in islets. In addition, the subsequent western blotting analysis of UCP2 in miRNA-overexpressed MIN6 cells confirmed these findings. The insulin determination by ELISA was also consistent with the prediction.
Here, high glucose was shown to have effects on the expression of miRNAs and UCP2 in β-cells, thus regulating insulin secretion. However, the upstream and downstream regulators have not yet been determined. High glucose was found to lead to the same variation in the four miRNAs in both wild-type and UCP2-deficient islets, indicating that these miRNAs were upstream regulators in the GSIS pathway.
In summary, miR-15a, miR-424, miR-497, and miR-185 were revealed to target β-cell UCP2 and regulate insulin secretion. Precise understanding of the role of miRNAs and their 
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